|The ANUBL1 zfand4 (Catalog #MBS859155) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The ANUBL1 Antibody reacts with Human
Predicted: Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s ANUBL1 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB), Immunohistochemistry (IHC).
IHC: 1:100-1:500. Researchers should empirically determine the suitability of the ANUBL1 zfand4 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The ANUBL1 zfand4 product has the following accession number(s) (GI #29124563) (NCBI Accession #BC048968). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the ANUBL1 Antibody with the following immunoassay(s):
Rabbit polyclonal ANUBL1 (1) antibody was raised against a recombinate human ANUBL1 protein 453-653aa (BC048968).
In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing ANUBL1 are readily searchable from our website. Different antibodies against the same target such as ANUBL1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Adenocarcinoma are some of the diseases may be linked to ANUBL1 Antibody.